CNO Financial Group, Inc. (CNO) Stock Analysis
Financial Services · Insurance - Life
Sell if holding. Analyst target reached at $44.25 — A.R:R is negative (-1.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Counterparty: seven largest reinsurers (99.0%).
CNO Financial Group develops and markets health insurance, annuities, and life insurance for middle-income pre-retiree and retired Americans under Bankers Life, Washington National, and Colonial Penn brands. Generated $4.5B revenue and held $38.8B total assets in 2025,... Read more
Sell if holding. Analyst target reached at $44.25 — A.R:R is negative (-1.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Counterparty: seven largest reinsurers (99.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Score 5.6/10, moderate confidence.
Passes 5/6 gates (positive momentum, clean insider activity, no SEC red flags, earnings proximity no date, semi cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- HIGHcounterpartyseven largest reinsurers99%10-K Item 1A: 'Our seven largest reinsurers, which are rated "A-" or higher by AM Best as of December 31, 2025, accounted for 97 percent of our ceded life insurance inforce and 99 percent of our reinsurance receivables.'
Material Events(8-K, last 90d)
- 2026-02-11Item 5.02LOWDirector Mary R. (Nina) Henderson informed Board she will retire at the 2026 annual meeting. Not based on any disagreement with the Company on any matter.SEC filing →
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. Full disclaimer
Rating Breakdown
1 floor-breaker
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Analyst target reached at $44.25 — A.R:R is negative (-1.5) — price has exceeded the analyst target. Reward from here is too thin for a buy — the engine flags exit. Additional concerns: Concentration risk — Counterparty: seven largest reinsurers (99.0%). Chart setup: No recognized chart pattern (not a breakout, bounce, continuation, recovery, falling knife, or range) — technicals mixed. Prior stop was $42.69. Score 5.6/10, moderate confidence.
Take-profit target: $44.04 (-0.7% upside). Prior stop was $42.69. Stop-loss: $42.69.
Concentration risk — Counterparty: seven largest reinsurers (99.0%); Analyst target reached - limited upside remaining; Near 52-week high (1.3% away).
CNO Financial Group, Inc. trades at a P/E of 19.3 (forward 9.1). TrendMatrix value score: 7.8/10. Verdict: Sell.
10 analysts cover CNO with a consensus score of 3.6/5. Average price target: $46.
What does CNO Financial Group, Inc. do?CNO Financial Group develops and markets health insurance, annuities, and life insurance for middle-income pre-retiree...
CNO Financial Group develops and markets health insurance, annuities, and life insurance for middle-income pre-retiree and retired Americans under Bankers Life, Washington National, and Colonial Penn brands. Generated $4.5B revenue and held $38.8B total assets in 2025, distributed through exclusive agents, independent producers, and direct marketing.